These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15778403)

  • 1. In vitro and in vivo characterization of a novel antibody-like single-chain TCR human IgG1 fusion protein.
    Mosquera LA; Card KF; Price-Schiavi SA; Belmont HJ; Liu B; Builes J; Zhu X; Chavaillaz PA; Lee HI; Jiao JA; Francis JL; Amirkhosravi A; Wong RL; Wong HC
    J Immunol; 2005 Apr; 174(7):4381-8. PubMed ID: 15778403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivity.
    Card KF; Price-Schiavi SA; Liu B; Thomson E; Nieves E; Belmont H; Builes J; Jiao JA; Hernandez J; Weidanz J; Sherman L; Francis JL; Amirkhosravi A; Wong HC
    Cancer Immunol Immunother; 2004 Apr; 53(4):345-57. PubMed ID: 14610621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
    J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
    Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
    J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein.
    Belmont HJ; Price-Schiavi S; Liu B; Card KF; Lee HI; Han KP; Wen J; Tang S; Zhu X; Merrill J; Chavillaz PA; Wong JL; Rhode PR; Wong HC
    Clin Immunol; 2006 Oct; 121(1):29-39. PubMed ID: 16807113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel antibody-like TCRγδ-Ig fusion protein exhibits antitumor activity against human ovarian carcinoma.
    Zheng J; Guo Y; Ji X; Cui L; He W
    Cancer Lett; 2013 Dec; 341(2):150-8. PubMed ID: 23920126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
    Lev A; Novak H; Segal D; Reiter Y
    J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific roles of each TCR hemichain in generating functional chain-centric TCR.
    Nakatsugawa M; Yamashita Y; Ochi T; Tanaka S; Chamoto K; Guo T; Butler MO; Hirano N
    J Immunol; 2015 Apr; 194(7):3487-500. PubMed ID: 25710913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.
    Chames P; Willemsen RA; Rojas G; Dieckmann D; Rem L; Schuler G; Bolhuis RL; Hoogenboom HR
    J Immunol; 2002 Jul; 169(2):1110-8. PubMed ID: 12097420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of p53(264-272)/HLA-A*0201 complexes naturally presented on tumor cell surface by a multimeric soluble single-chain T cell receptor.
    Zhu X; Belmont HJ; Price-Schiavi S; Liu B; Lee HI; Fernandez M; Wong RL; Builes J; Rhode PR; Wong HC
    J Immunol; 2006 Mar; 176(5):3223-32. PubMed ID: 16493083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death.
    Wittman VP; Woodburn D; Nguyen T; Neethling FA; Wright S; Weidanz JA
    J Immunol; 2006 Sep; 177(6):4187-95. PubMed ID: 16951384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
    Peng LS; Penichet ML; Morrison SL
    J Immunol; 1999 Jul; 163(1):250-8. PubMed ID: 10384123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a novel fusion protein composed of a human IgG1 heavy chain constant region and a single-chain fragment variable antibody against Venezuelan equine encephalitis virus.
    Hu WG; Alvi AZ; Chau D; Coles JE; Fulton RE; Suresh MR; Nagata LP
    J Biochem; 2003 Jan; 133(1):59-66. PubMed ID: 12761199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
    Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
    Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
    Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo.
    Lev A; Noy R; Oved K; Novak H; Segal D; Walden P; Zehn D; Reiter Y
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9051-6. PubMed ID: 15184663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted bioactivity of membrane-anchored TNF by an antibody-derived TNF fusion protein.
    Bauer S; Adrian N; Williamson B; Panousis C; Fadle N; Smerd J; Fettah I; Scott AM; Pfreundschuh M; Renner C
    J Immunol; 2004 Mar; 172(6):3930-9. PubMed ID: 15004201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
    Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
    Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
    Govers C; Sebestyén Z; Roszik J; van Brakel M; Berrevoets C; Szöőr Á; Panoutsopoulou K; Broertjes M; Van T; Vereb G; Szöllősi J; Debets R
    J Immunol; 2014 Nov; 193(10):5315-26. PubMed ID: 25320284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunization with a soluble TCR-Ig chimeric protein: long term, V beta-8 family-specific suppression of T cells by maternally transferred antibodies.
    McKeever U; Khandekar S; Jesson M; Newcomb J; Gregory P; Naylor J; Haskins K; Jones B
    J Immunol; 1997 Dec; 159(12):5936-45. PubMed ID: 9550391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.